PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Global_Chief_Interna_Auditor_Survey_Fina_June_2024_GER - Deloitte | Presentation Nation

HomepageDeloitteGlobal_Chief_Interna_Auditor_Survey_Fina_June_2024_GER

Global_Chief_Interna_Auditor_Survey_Fina_June_2024_GER

Deloitte

Browse presentations, reports, and documents from Deloitte.

Tags

2024

Filter options

All (310)●
whitepaper (7)○
investor_presentation (1)○
case-study (2)○
presentation (54)○
report (25)○
conference (1)○
infographic (76)○
magazine (1)○
brochure (143)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

Global_Chief_Interna_Auditor_Survey_Fina_June_2024_GER by Deloitte.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Deloitte

1237494208965

case-study

2019-Deloitte-and-MAPI-Smart-Factory-Study

brochure

Similar presentations from other companies

Borr-Drilling-Fleet-Availability-November-2019-1

presentation

Borr Drilling Limited

Intercept Pharmaceuticals_May_2021_346_69346

presentation

Intercept Pharmaceuticals

2019-global-shared-services-infographic

infographic

2019-global-shared-services-survey-results

presentation

2020-global-aerospace-defence-outlook

brochure

2021-health-care-outlook-final

brochure

Arch Capital Group_June_2021_457_72457

presentation

Arch Capital Group Limited

Motorsport Games_June_2021_271_71271

presentation

Motorsport Games

Main Street Capital_February_2021_462_66462

presentation

Main Street Capital

Esperion Therapeutics_August_2022_484_87484

presentation

Esperion Therapeutics